Jocelyne Bloch, MD
CHUV
Emerging Leaders
#453 pts
Current Leaders
#6,5985 pts
All-Time Leaders
#7453 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2021. 9 trials as lead/chair. How it works →
Trials led — by scientific impact
Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury
N/ARecruitingEcole Polytechnique Fédérale de Lausanne
9
impact
Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury
N/ARecruitingEcole Polytechnique Fédérale de Lausanne
8
impact
Brain-controlled Spinal Cord Stimulation in Participants With Chronic Stroke for Lower and Upper Limb Rehabilitation
N/ARecruitingEcole Polytechnique Fédérale de Lausanne
8
impact
Restoring Hemodynamic Stability Using Targeted Epidural Spinal Stimulation Following Spinal Cord Injury
N/ATerminatedJocelyne Bloch
7
impact
STIMO-PARKINSON: Study on Feasibility of Targeted Epidural Spinal Stimulation (TESS) to Improve Mobility in Patients With Parkinson's Disease
N/ACompletedJocelyne Bloch
6
impact
Deep Brain Stimulation of the Lateral Hypothalamus to Augment Motor Function of Patients With Spinal Cord Injury
N/AUnknownJocelyne Bloch
6
impact
Brain Controlled Spinal Cord Stimulation In Participants With Spinal Cord Injury For Lower Limb Rehabilitation
N/AActiveEcole Polytechnique Fédérale de Lausanne
5
impact
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
N/ARecruitingEcole Polytechnique Fédérale de Lausanne
4
impact
Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Support Hemodynamic Management in People With Typical and Atypical Parkinson's Disease
N/ARecruitingEcole Polytechnique Fédérale de Lausanne
0
impact